INBICON A/S: Financial statements 2021
CVR: 27036635
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
INBICON A/S (CVR 27036635) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -518,000 and a net result of DKK -1,611,000 compared with DKK 21,322,000 the year before. Equity in the 2021 report amounted to DKK 32,001,000. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -518,000
- Profit/Loss
- DKK -1,611,000
- Equity
- DKK 32,001,000
- Total Assets
- DKK 32,010,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -518 t. | -1.6 mio. | 32 mio. | - |
| 2020 | 0 | 25.7 mio. | 21.3 mio. | 33.6 mio. | - |
| 2019 | - | 4.6 mio. | 3.5 mio. | 12.3 mio. | - |
| 2018 | - | -16.3 mio. | -12.7 mio. | 8.8 mio. | - |
| 2017 | - | -4.4 mio. | -7.6 mio. | 21.5 mio. | - |
Official annual report
Find more companies like INBICON A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
INBICON A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 21,322,000.
As of February 15, 2021, Mikael Brandt has joined the board of directors of INBICON A/S.
As of February 15, 2021, Hanne Risbjerg Sørensen has joined the board of directors of INBICON A/S.
As of February 15, 2021, Morten Hultberg Buchgreitz has left the board of directors of INBICON A/S.
As of February 14, 2021, Mikael Brandt has left the board of directors of INBICON A/S.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.